Join previous FDA Commissioners and the FDA Oncology Center of Excellence, in recognizing a quarter century of federal government service by OCE Center Director, Dr. Richard Pazdur. The esteemed panel will highlight the many oncology advances and changes at FDA throughout Dr. Pazdur’s tenure. The panel discussion takes place October 23, 2024, from 2:00 pm to 3:00 pm ET and will focus on Dr. Pazdur’s unceasing and continuing service to the global oncology community.
During his 25 years of oncology leadership at the FDA, Dr. Pazdur has served with seven FDA Commissioners. Register now to watch this unique panel discussion with some of those FDA Commissioners and Dr. Pazdur.
For anyone who might be unaware, Richard Pazdur, M.D., is director of the FDA Oncology Center of Excellence, which leverages the combined skills of FDA’s scientists and reviewers with expertise in drugs, biologics, and devices to expedite the development of novel cancer products.
Prior to joining FDA in 1999, Dr. Pazdur was a professor of medicine, Assistant Vice President for Academic Affairs, and director of the oncology fellowship program at The University of Texas M.D. Anderson Cancer Center. From 1982 to 1988, he served on the faculty of Wayne State University.
Dr. Pazdur has published more than 600 articles, book chapters, and abstracts, and received many awards, including recognition in Fortune magazine’s 2015 list of “50 World’s Greatest Leaders,” the Massachusetts General Hospital Cancer Center’s “The One Hundred” list in 2016, and one of “The Bloomberg 50” in 2017.
Join us October 23rd to celebrate Dr. Pazdur’s notable oncology career and his ongoing service to FDA.